News

EIT Health 2025 Bootcamps for start-ups: Apply now!

Published on | 10 months ago

Programmes Health EIT

EIT Health is currently calling for applications for several health bootcamp programmes. These are intensive incubation programmes for start-ups. The programmes gives start-ups the chance to explore their full-market potential and connect with a network of fellow innovators across Europe.

Themes of the 2025 Bootcamps:

Please be aware taking part in these calls is not always for free. We advise you to read carefully the participation rules in advance.

More information available on the EIT Health website. Or join the EIT Health's info webinar on 27 March 2025.

If you are interested in one (or more) of these programmes, don't hesitate to contact the EIT Health Belgium-Netherlands hub. E-Mail: bene.office@eithealth.eu . 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1786 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.